BIT:PHIL - IT0005373789 - Common Stock
The current stock price of PHIL.MI is 23.9 EUR. In the past month the price increased by 6.79%. In the past year, price increased by 10.8%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 19.74 | 316.57B | ||
1ABBV.MI | ABBVIE INC | 19.58 | 314.07B | ||
AMG.DE | AMGEN INC | 13.05 | 131.47B | ||
1GILD.MI | GILEAD SCIENCES INC | 14.78 | 122.10B | ||
GIS.DE | GILEAD SCIENCES INC | 14.52 | 119.60B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | 23.06 | 85.89B | ||
ARGX.BR | ARGENX SE | 81.75 | 37.07B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 20.78B | ||
IDP.DE | BIOGEN INC | 8.27 | 16.64B | ||
1MRNA.MI | MODERNA INC | N/A | 8.13B | ||
0QF.DE | MODERNA INC | N/A | 8.01B | ||
1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.52B |
Philogen SpA engages in the engineering and clinical development of lead products capable of targeting angiogenesis. The company is headquartered in Sovicille, Siena and currently employs 183 full-time employees. The company went IPO on 2021-03-03. The firm develops products and technologies for the diagnosis and therapy of serious human diseases. The company focuses mainly on discovering and developing targeted anti-cancer drugs, using high-affinity ligands for tumor markers. These ligands are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The Company’s products primarily address applications in the oncology field, the targeting approach is also potentially applicable to other diseases, such as certain chronic inflammatory diseases. The company has four anti-cancer antibody derivatives in clinical studies, one of which has completed a Phase III trial. The firm is active in the Discovery Unit through its subsidiary Philochem AG.
PHILOGEN SPA
Via Bellaria, 35
Sovicille SIENA IT
Employees: 183
Phone: 39057717816
The current stock price of PHIL.MI is 23.9 EUR. The price increased by 1.27% in the last trading session.
The exchange symbol of PHILOGEN SPA is PHIL and it is listed on the Euronext Milan exchange.
PHIL.MI stock is listed on the Euronext Milan exchange.
8 analysts have analysed PHIL.MI and the average price target is 30.6 EUR. This implies a price increase of 28.03% is expected in the next year compared to the current price of 23.9. Check the PHILOGEN SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PHILOGEN SPA (PHIL.MI) has a market capitalization of 698.84M EUR. This makes PHIL.MI a Small Cap stock.
PHILOGEN SPA (PHIL.MI) currently has 183 employees.
PHILOGEN SPA (PHIL.MI) has a support level at 22.53 and a resistance level at 23.7. Check the full technical report for a detailed analysis of PHIL.MI support and resistance levels.
The Revenue of PHILOGEN SPA (PHIL.MI) is expected to grow by 181.17% in the next year. Check the estimates tab for more information on the PHIL.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PHIL.MI does not pay a dividend.
PHILOGEN SPA (PHIL.MI) will report earnings on 2025-09-23.
The PE ratio for PHILOGEN SPA (PHIL.MI) is 21.34. This is based on the reported non-GAAP earnings per share of 1.12 and the current share price of 23.9 EUR. Check the full fundamental report for a full analysis of the valuation metrics for PHIL.MI.
ChartMill assigns a technical rating of 5 / 10 to PHIL.MI. When comparing the yearly performance of all stocks, PHIL.MI turns out to be only a medium performer in the overall market: it outperformed 56.55% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to PHIL.MI. While PHIL.MI has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months PHIL.MI reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS increased by 824.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 61.21% | ||
ROA | 26.89% | ||
ROE | 32.66% | ||
Debt/Equity | 0.08 |
8 analysts have analysed PHIL.MI and the average price target is 30.6 EUR. This implies a price increase of 28.03% is expected in the next year compared to the current price of 23.9.
For the next year, analysts expect an EPS growth of 56.07% and a revenue growth 181.17% for PHIL.MI